Rainbow Extension Study
Rainbow Extension Study
The purpose of this study is to evaluate the long term efficacy and safety of intravitreal
 ranibizumab compared with laser ablation therapy in patients who were treated for retinopathy
 of prematurity (ROP) in the core study CRFB002H2301
Inclusion Criteria:

 -  The patient successfully completed the core study CRFB002H2301

 -  The patient received study treatment in both eyes at baseline of study CRFB002H2301

 Exclusion Criteria:

 -  Patient has a medical condition or personal circumstance which precludes study
 participation or compliance with study procedures, as assessed by the Investigator

 -  Patient has been discontinued from the core study CRFB002H2301 at any time

 Other protocol-defined inclusion/exclusion criteria may apply